SEC Form 4 · accession 0001179110-18-010052
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Weber
Officer — Chief Operating Officer
Period of report
Jul 30, 2018
Accepted (ET)
Aug 1, 2018 · 4:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 par valueF5 | Jul 30, 2018 | M | 11,000 | $22.44 | A | 167,124 | D | |
| Common Stock, $.01 par valueF6,F7 | Jul 30, 2018 | S | 400 | $352.1475 | D | 166,724 | D | |
| Common Stock, $.01 par valueF6,F8 | Jul 30, 2018 | S | 1,000 | $353.255 | D | 165,724 | D | |
| Common Stock, $.01 par valueF6,F9 | Jul 30, 2018 | S | 2,087 | $354.1832 | D | 163,637 | D | |
| Common Stock, $.01 par valueF6,F10 | Jul 30, 2018 | S | 2,400 | $355.1267 | D | 161,237 | D | |
| Common Stock, $.01 par valueF6,F11 | Jul 30, 2018 | S | 4,794 | $356.2331 | D | 156,443 | D | |
| Common Stock, $.01 par valueF6,F12 | Jul 30, 2018 | S | 4,001 | $357.0892 | D | 152,442 | D | |
| Common Stock, $.01 par valueF6,F13 | Jul 30, 2018 | S | 1,200 | $358.1467 | D | 151,242 | D | |
| Common Stock, $.01 par valueF6,F14 | Jul 30, 2018 | S | 1,500 | $359.056 | D | 149,742 | D | |
| Common Stock, $.01 par valueF6,F15 | Jul 30, 2018 | S | 400 | $360.3825 | D | 149,342 | D | |
| Common Stock, $.01 par valueF6,F16 | Jul 30, 2018 | S | 400 | $360.8525 | D | 148,942 | D | |
| Common Stock, $.01 par valueF6 | Jul 30, 2018 | S | 100 | $362.64 | D | 148,842 | D | |
| Common Stock, $.01 par valueF6,F17 | Jul 30, 2018 | S | 400 | $363.05 | D | 148,442 | D | |
| Common Stock, $.01 par valueF6,F18 | Jul 30, 2018 | S | 300 | $363.96 | D | 148,142 | D | |
| Common Stock, $.01 par valueF6 | Jul 30, 2018 | S | 100 | $365.00 | D | 148,042 | D | |
| Common Stock, $.01 par valueF6 | Jul 30, 2018 | S | 200 | $365.91 | D | 147,842 | D | |
| Common Stock, $.01 par value | holding | — | — | — | 15,497 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F5,F1 | $22.44 | Jul 30, 2018 | M | 11,000 | D | May 22, 2013 | May 22, 2022 | Common Stock | 11,000 | 14,000 | D |
| Stock Option (Right to Buy)F2,F1 | $23.15 | holding | — | — | — | May 14, 2014 | May 14, 2023 | Common Stock | 0 | 23,000 | D |
| Stock Option (Right to Buy)F2,F3 | $21.55 | holding | — | — | — | May 14, 2015 | May 14, 2024 | Common Stock | 0 | 15,000 | D |
| Stock Option (right to buy)F2,F3 | $66.25 | holding | — | — | — | May 13, 2016 | May 13, 2025 | Common Stock | 0 | 10,000 | D |
| Stock Option (right to buy)F4,F3 | $99.62 | holding | — | — | — | May 24, 2017 | May 24, 2026 | Common Stock | 0 | 7,000 | D |
| Stock Option (right to buy)F4,F3 | $134.51 | holding | — | — | — | May 15, 2018 | May 15, 2027 | Common Stock | 0 | 8,000 | D |
| Stock Option (right to buy)F4,F3 | $381.97 | holding | — | — | — | May 16, 2019 | May 16, 2028 | Common Stock | 0 | 6,500 | D |
Explanation of responses
- F1This option becomes exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- F10This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $354.7400 and $355.6300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F11This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $355.7500 and $356.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F12This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $356.6700 and $357.5900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F13This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $357.6800 and $358.5200. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F14This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $358.6900 and $359.6500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F15This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $359.7300 and $360.6400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F16This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $360.7200 and $361.0100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F17This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $362.7500 and $363.500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F18This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $363.7200 and $364.3100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F2Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F3These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- F4Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- F5Exercise of stock options pursuant to reporting owners 10b5-1 plan.
- F6Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- F7This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $351.6600 and $352.5100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F8This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $352.7300 and $353.6500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F9This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $353.7800 and $354.5300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.